Literature DB >> 315186

An appraisal of maximal faradic stimulation of pelvic muscles in the management of female urinary incontinence.

A G Turner.   

Abstract

Measurement of the urethral pressure profile enables a group of women to be defined whose urinary incontinence is due to sphincter weakness. In such cases a significant degree of improvement, both symptomatic and in the profile amplitude, follows treatment by maximal faradic stimulation of the pelvic muscle and perineal muscle exercises.

Entities:  

Mesh:

Year:  1979        PMID: 315186      PMCID: PMC2492238     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  8 in total

1.  SIMULTANEOUS INTRAURETHRAL AND INTRAVESICAL PRESSURE STUDIES IN NORMAL WOMEN AND THOSE WITH STRESS INCONTINENCE.

Authors:  R P BECK; G B MAUGHAN
Journal:  Am J Obstet Gynecol       Date:  1964-07-15       Impact factor: 8.661

2.  Direct urethrocystometry.

Authors:  G P HODGKINSON
Journal:  Am J Obstet Gynecol       Date:  1960-04       Impact factor: 8.661

3.  The urethral pressure profile: theoretical considerations and clinical application.

Authors:  L Edwards; J Malvern
Journal:  Br J Urol       Date:  1974-06

4.  Intravesical and intraurethral pressure as a measure of urethral sphincter function.

Authors:  J A Low; M S Kao
Journal:  Obstet Gynecol       Date:  1972-11       Impact factor: 7.661

5.  Synchronous cine-pressure-flow-cysto-urethrography with special reference to stress and urge incontinence.

Authors:  C P Bates; C G Whiteside; R Turner-Warwick
Journal:  Br J Urol       Date:  1970-12

6.  The urethral pressure profile.

Authors:  M Brown; J E Wickham
Journal:  Br J Urol       Date:  1969-04

7.  Treatment of stress incontinence by maximum perineal electrical stimulation.

Authors:  T Moore; P F Schofield
Journal:  Br Med J       Date:  1967-07-15

8.  Intraurethral and intravesical pressures in normal and stress-incontinent women.

Authors:  H A Toews
Journal:  Obstet Gynecol       Date:  1967-05       Impact factor: 7.661

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.